There are currently 608 clinical trials in Sacramento, California looking for participants to engage in research studies. Trials are conducted at various facilities, including University of California Davis Comprehensive Cancer Center, University of California Davis Medical Center, University Of California Davis and Sutter Medical Center Sacramento. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
NCT04314752
Recruiting
The objectives of the proposed study are to develop and evaluate protocols for ethnic/racial minority-specific research using cancer registry data. In conjunction with the Cancer Registry of Greater California (CRGC), the investigators have developed procedures to identify, recruit, and survey ethnic/racial minority patients with MM. To pilot the study, the investigators aim initially to test the feasibility of this protocol by contacting 400 eligible patients (100 African Americans, 100 Latinos... Read More
Gender:
ALL
Ages:
21 years and above
Trial Updated:
11/07/2024
Locations: University of California Davis Comprehensive Cancer Center, Sacramento, California
Conditions: Multiple Myeloma
Register for Updates
Accuracy of Pulse CO-Oximetry Technology in Characterizing Noninvasive SpHb
NCT01997502
Recruiting
This protocol is a request from Masimo to assist in the collection of data to be used to further refine the accuracy of the monitor's algorithm.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/06/2024
Locations: UC Davis Health, Sacramento, California
Conditions: Surgery, Hemoglobin
Register for Updates
Oxybutynin for Post-surgical Bladder Pain and Urgency
NCT03952299
Recruiting
Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.
Gender:
ALL
Ages:
Between 4 years and 8 years
Trial Updated:
11/06/2024
Locations: University of California Davis Medical Center (UCDMC), Sacramento, California
Conditions: Overactive Bladder Syndrome, Neuropathic Bladder
Register for Updates
Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors
NCT04485416
Recruiting
Primary Objective: To assess safety of eltrombopag in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Secondary Objectives: To assess the efficacy of eltrombopag in increasing platelet count up to 2 weeks after completion of chemotherapy in pediatric patients undergoing intensive chemotherapy for malignant solid tumors. Hypothesis: The hypothesis is that eltrombopag an oral thrombopoietin receptor agonist will increase the platelet count safely and efficaciousl... Read More
Gender:
ALL
Ages:
Between 1 year and 18 years
Trial Updated:
11/05/2024
Locations: University of California Davis Health System, Comprehensive Cancer Center, Sacramento, California
Conditions: Solid Tumor, Childhood, Solid Tumor
Register for Updates
Outcomes of Running Locking Suture vs Standard Running Suture in Surgical Wounds
NCT06288009
Recruiting
When patients have surgery on the head and face, stitches are the standard way to close the wound. Wounds always result in a scar, but doctors are always looking for ways to reduce scarring. Several studies have been done to test ways to close wounds that reduce scarring. The most commonly performed closure technique uses running sutures, where a single strand of suture is continued along the length of the wound with a series of uninterrupted stiches. However, alternative closure techniques exis... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/05/2024
Locations: University of California, Davis - Dermatology Department, Sacramento, California
Conditions: Scarring
Register for Updates
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
NCT04724252
Recruiting
The primary objective of this study is to determine if the peri and post operative use of gabapentin in children reduces the need for narcotics after thoracic surgery. We hypothesize that patients who are given gabapentin will need fewer morphine equivalents postoperatively than those who were not given gabapentin
Gender:
ALL
Ages:
17 years and below
Trial Updated:
10/31/2024
Locations: UC Davis Medical Center, Sacramento, California
Conditions: Pain, Postoperative
Register for Updates
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05929768
Recruiting
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be bette... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/29/2024
Locations: Mercy Cancer Center - Sacramento, Sacramento, California +1 locations
Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Register for Updates
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
NCT06005285
Recruiting
This study tests the effectiveness of the Early Start Denver Model (ESDM) in community agencies that serve young autistic children. The feasibility, usability and acceptability of the model will be explored. Understanding effectiveness of new evidence-based models will increase the quality of autism care available to more diverse children and families in more geographic locations.
Gender:
ALL
Ages:
12 months and above
Trial Updated:
10/29/2024
Locations: University of California, Davis MIND Institute, Sacramento, California
Conditions: Autism
Register for Updates
Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis
NCT05451212
Recruiting
Muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG) is a rare but potentially severe disease, in which patients develop pathogenic autoantibodies that specifically target the MuSK protein in the neuromuscular junction. This phase 1 study is being conducted to evaluate the safety of various dosing regimens of an investigational cell therapy, MuSK-CAART, that can be given to patients with anti-MuSK antibody positive Myasthenia Gravis (MuSK MG), who have active disease. Various dosing reg... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/25/2024
Locations: UC Davis, Department of Neurology, Sacramento, California
Conditions: MuSK Myasthenia Gravis
Register for Updates
Feasibility and Colorectal Benefits of Pulses Supplementation
NCT06032104
Recruiting
Beans are a forgotten staple food that shows promise in improving health. The goal of this study is to look at how bean supplementation affects metabolic and bowel health. In the long-term, the investigators believe this research will lead to a better understanding of the impact of beans on bowel health. The investigators also hope that this research study will help us understand ways to improve human diet and prevent colon cancer in the future.
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
10/25/2024
Locations: University of California Davis, Sacramento, California
Conditions: Colorectal Polyp, Obesity
Register for Updates
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
NCT05486572
Recruiting
The study is a randomized trial of two different screening methods for early detection of liver cancer in patients with cirrhosis of the liver. The goal of PREMIUM is to compare an abbreviated version of the diagnostic gold standard for HCC (aMRI) +AFP to the standard-of-care screening (US+AFP) in patients at high risk of developing HCC. The investigators hypothesize that HCC will be detected at earlier stages, allowing for more curative treatments and resulting in a reduction in HCC-related mor... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/24/2024
Locations: VA Northern California Health Care System, Mather, CA, Sacramento, California
Conditions: Carcinoma, Hepatocellular, Cirrhosis
Register for Updates
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
NCT05422534
Recruiting
Frailty and sarcopenia are modifiable risk factors for morbidity and mortality in patients with ESRD. Exercise is the recommended intervention to prevent frailty and sarcopenia, however, many clinical trials have shown limited clinical improvement in muscle mass and physical function. We propose that mitochondrial dysfunction is one of the deterrents to the effectiveness of the exercise. We plan to evaluate the additive effect of HIIT and CoQ10, a mitochondrial-targeted therapy, on mitochondrial... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
10/23/2024
Locations: University of California Davis Health, Sacramento, California
Conditions: End Stage Renal Disease
Register for Updates